Low RORα mRNA was also associated with a better prognosis in intestinal-type GC [HR = 1.51, 95% CI: (1.09–2.11), P = 0.013] (Figure 2b), as well as in diffuse-type GC [HR = 1.83, 95% CI: (1.3–2.59), P = 0.00045] (Figure 2c). The gene discussed is RORA; the disease is gastric cancer.